Igor Mochalkin

Igor Mochalkin

Vertex Pharmaceuticals - Boston / United States
Natural Sciences / Chemical Sciences
AD Scientific Index ID: 4613981
-
person_outline Igor Mochalkin's MOST POPULAR ARTICLES
1-) Molecular mechanisms of initiation of fibrinolysis by fibrinD Collen, HR Lijnen, E Suenson, P Bjerrum, A Holm, B Lind, M Meldal, ...Thrombosis and haemostasis 89 (03), 409-419, 20033042003
2-) Inhibition of RAF isoforms and active dimers by LY3009120 leads to anti-tumor activities in RAS or BRAF mutant cancersSB Peng, JR Henry, MD Kaufman, WP Lu, BD Smith, S Vogeti, ...Cancer cell 28 (3), 384-398, 20152842015
3-) A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptidesZ Yang, I Mochalkin, RF DoolittleProceedings of the National Academy of Sciences 97 (26), 14156-14161, 20002832000
4-) Large-scale assessment of binding free energy calculations in active drug discovery projectsCEM Schindler, H Baumann, A Blum, D Böse, HP Buchstaller, ...Journal of Chemical Information and Modeling 60 (11), 5457-5474, 20202152020
5-) A class of selective antibacterials derived from a protein kinase inhibitor pharmacophoreJR Miller, S Dunham, I Mochalkin, C Banotai, M Bowman, S Buist, ...Proceedings of the National Academy of Sciences 106 (6), 1737-1742, 20091742009